Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency

CONTEXT: Fludrocortisone (FC) is the mineralocorticoid (MC) replacement treatment for patients with primary adrenal insufficiency (PAI). OBJECTIVE: To explore the dose of FC treatment and its relationship with glucocorticoid therapy, sodium, potassium, renin and clinical parameters. SETTING: Monocen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceccato, F., Torchio, M., Tizianel, I., Peleg Falb, M., Barbot, M., Sabbadin, C., Betterle, C., Scaroni, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829625/
https://www.ncbi.nlm.nih.gov/pubmed/35947299
http://dx.doi.org/10.1007/s40618-022-01889-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829625/
https://www.ncbi.nlm.nih.gov/pubmed/35947299
http://dx.doi.org/10.1007/s40618-022-01889-1

Ejemplares similares